To address the current national emergency, U.S. entities may be eligible to license select Sandia intellectual property at no cost for a limited time. Learn more.

Search/Browse Tech

Endpoint detection of amplified nucleic acids

United States Patent

To discuss licensing opportunities, fill out our Contact Form 
10,724,091
July 28, 2020
View the Complete Patent at the US Patent & Trademark Office
The present invention relates to probes and primers beneficial for conducting amplification assays, such as those including loop-mediated isothermal amplification reactions. Also described herein are methods for detecting targets using such probes and/or primers.
15/008,285
January 27, 2016
1/1;
C12Q 1/6876 (20180101); C12Q 1/6818 (20180101);
STATEMENT OF GOVERNMENT INTEREST This invention was made with Government support under contract no. DE-AC04-94AL85000 awarded by the U.S. Department of Energy to Sandia Corporation and under contract no. R01AI098853 awarded by the National Institute of Allergy and Infectious Diseases (NIAID). The Government has certain rights in the invention.